BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK
388 results:

  • 1. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
    Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
    PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Estimating the Prognostic Value of the Ntrk Fusion Biomarker for Comparative Effectiveness Research in The Netherlands.
    Santi I; Vellekoop H; M Versteegh M; A Huygens S; Dinjens WNM; Mölken MR
    Mol Diagn Ther; 2024 May; 28(3):319-328. PubMed ID: 38616205
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Precision nanomedicine to treat non-small cell lung cancer.
    Dessai A; Nayak UY; Nayak Y
    Life Sci; 2024 Jun; 346():122614. PubMed ID: 38604287
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcomes and costs with the introduction of robotic-assisted thoracic surgery in public hospitals.
    Betser L; Le Bras A; Etienne H; Roussel A; Bobbio A; Al-Zreibi C; Martinod E; Alifano M; Castier Y; Assouad J; Durand-Zaleski I; Mordant P
    J Robot Surg; 2024 Mar; 18(1):124. PubMed ID: 38492119
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel EML4-Ntrk3 fusion in lung adenocarcinoma with dramatic response to entrectinib.
    Batra U; Nathany S; Sharma M; Jain P; Mehta A; Bansal A
    J Cancer Res Ther; 2023 Oct; 19(7):2045-2047. PubMed ID: 38376315
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. 2021 WHO Classification of lung cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
    Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
    Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Meta-analysis of microarray data to determine gene indicators involved in cisplatin resistance in non-small cell lung cancer.
    Sheikhshabani SH; Modarres P; Ghafouri-Fard S; Amini-Farsani Z; Khodaee L; Shaygan N; Amini-Farsani Z; Omrani MD
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1970. PubMed ID: 38351531
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-trk-0315).
    Sebastian M; Eberhardt WEE; von der Heyde E; Dörfel S; Wiegand J; Schiefer C; Losem C; Jänicke M; Fleitz A; Zacharias S; Kaiser-Osterhues A; Hipper A; Dietel C; Bleckmann A; Benkelmann R; Boesche M; Grah C; Müller A; Griesinger F; Thomas M;
    Int J Cancer; 2024 Jun; 154(11):1967-1978. PubMed ID: 38329180
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Repotrectinib: First Approval.
    Dhillon S
    Drugs; 2024 Feb; 84(2):239-246. PubMed ID: 38279972
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of Ntrk expression and fusions in a large cohort of early-stage lung cancer.
    Dyrbekk APH; Warsame AA; Suhrke P; Ludahl MO; Zecic N; Moe JO; Lund-Iversen M; Brustugun OT
    Clin Exp Med; 2024 Jan; 24(1):10. PubMed ID: 38240952
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic and predictive biomarkers in non-small cell lung carcinoma.
    Odintsov I; Sholl LM
    Pathology; 2024 Mar; 56(2):192-204. PubMed ID: 38199926
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Updated efficacy and safety of entrectinib in Ntrk fusion-positive non-small cell lung cancer.
    Cho BC; Chiu CH; Massarelli E; Buchschacher GL; Goto K; Overbeck TR; Loong HHF; Chee CE; Garrido P; Dong X; Fan Y; Lu S; Schwemmers S; Bordogna W; Zeuner H; Osborne S; John T
    Lung Cancer; 2024 Feb; 188():107442. PubMed ID: 38171156
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A clinical perspective on ectopic Cushing's syndrome.
    Ragnarsson O; Juhlin CC; Torpy DJ; Falhammar H
    Trends Endocrinol Metab; 2024 Apr; 35(4):347-360. PubMed ID: 38143211
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Oncogenic fusions: Targeting Ntrk.
    Hagopian G; Nagasaka M
    Crit Rev Oncol Hematol; 2024 Feb; 194():104234. PubMed ID: 38122917
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ETV6::Ntrk3 gene fusion in a patient with metastatic lung atypical carcinoid successfully treated with repotrectinib: A case report.
    Gao L; Ai X; Lu S
    Lung Cancer; 2024 Jan; 187():107443. PubMed ID: 38113652
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
    Zhao X; Yang M; Fan J; Wang M; Wang Y; Qin N; Zhu M; Jiang Y; Gorlova OY; Gorlov IP; Albanes D; Lam S; Tardón A; Chen C; Goodman GE; Bojesen SE; Landi MT; Johansson M; Risch A; Wichmann HE; Bickeböller H; Christiani DC; Rennert G; Arnold SM; Brennan P; Field JK; Shete S; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Woll PJ; Lazarus P; Schabath MB; Aldrich MC; Patel AV; Davies MPA; Ma H; Jin G; Hu Z; Amos CI; Shen H; Dai J
    Cancer; 2024 Mar; 130(6):913-926. PubMed ID: 38055287
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Misleading Case of Ntrk-Rearranged Papillary Thyroid Carcinoma.
    Germani MM; Boccaccio C; Matrone A; Molinaro E; Alì G; Giordano M; Elisei R; Fontanini G; Cremolini C
    Oncologist; 2024 Jan; 29(1):84-88. PubMed ID: 38037189
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Detection of Ntrk fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment.
    de Oliveira Cavagna R; de Andrade ES; Tadin Reis M; de Paula FE; Noriz Berardinelli G; Bonatelli M; Ramos Teixeira G; Garbe Zaniolo B; Mourão Dias J; da Silva FAF; Baston Silva CE; Xavier Reis M; Lopes Maia E; de Alencar TS; Jacinto AA; da Nóbrega Oliveira REN; Molina-Vila MA; Ferro Leal L; Reis RM
    Sci Rep; 2023 Dec; 13(1):21168. PubMed ID: 38036758
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A case of a shrunken multilocular mediastinal cyst that developed into thymic carcinoma with lung metastases 13 years later.
    Sugai K; Nakaoka K; Tobita R; Kikuchi S; Inoue K; Enokido M; Kiyoshima M
    Thorac Cancer; 2024 Jan; 15(1):94-97. PubMed ID: 38018322
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Analysis of CD74 Occurrence in Oncogenic Fusion Proteins.
    Vargas J; Pantouris G
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958963
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 20.